HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

MiPE protocol

combination of Cisplatin, Vindesine & Mitomycin; used in treatment of non-small cell lung neoplasms
Also Known As:
CMV protocol 2; MVP regimen; PVM protocol
Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ding, Zhengping: 1 article (02/2008)
2. Zheng, Min: 1 article (02/2008)
3. Zhou, Yunzhong: 1 article (02/2008)
4. Shentu, Yang: 1 article (02/2008)
5. Chen, Gang: 1 article (02/2008)
6. Ke, Yuhua: 1 article (06/2003)
7. Fan, Yuhua: 1 article (06/2003)
8. Yang, Ling: 1 article (06/2003)
9. Fu, Xiaoyu: 1 article (06/2003)
10. Zhou, Yunhua: 1 article (06/2003)

Related Diseases

1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
2. Neoplasms (Cancer)
3. Non-Hodgkin Lymphoma (Lymphosarcoma)
4. Lung Neoplasms (Lung Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Mitomycin (Mitomycin-C)
2. Cisplatin (Platino)
3. Epirubicin (Ellence)
4. Mesna (Coenzyme M)
5. Vinblastine (Vinblastine Sulfate)
6. Ifosfamide
7. Etoposide (VP 16)
8. Prednisone (Sone)
9. Mitoxantrone (Novantrone)

Related Therapies and Procedures

1. Combination Drug Therapy (Combination Chemotherapy)
2. Palliative Care (Palliative Medicine)